Trevena's TRV027 misses heart failure endpoint

Trevena Inc. (NASDAQ:TRVN) slipped $0.50 to $6.32 on Monday after its TRV027 missed the primary and secondary

Read the full 179 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE